| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.36 | 0.04 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.04 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.04 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.36 | 0.04 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.04 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.31 | 0.04 |